World Health Organization. Basic documents: forty-ninth edition (including amendments adopted up to 31 May 2019). Geneva: World Health Organization; 2020.
Parcesepe AM, Stockton M, Remch M, Wester CW, Bernard C, Ross J, et al. Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020. J Int AIDS Soc Agosto. 2023;26(8):e26147.
Google Scholar
Antiretroviral Therapy Cohort Collaboration, Zwahlen M, Harris R, May M, Hogg R, Costagliola D, et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol Dicembre. 2009;38(6):1624–33.
Google Scholar
Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL et al. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda. Ann Intern Med. 16 agosto. 2011;155(4):209–16.
Taiwo BO, Romdhani H, Lafeuille MH, Bhojwani R, Milbers K, Donga P. Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews. J Drug Assess. 2023;12(1):1–11.
Google Scholar
Gooden TE, Gardner M, Wang J, Chandan JS, Beane A, Haniffa R, et al. The risk of mental illness in people living with HIV in the UK: a propensity score-matched cohort study. Lancet HIV 1 Marzo. 2022;9(3):e172–81.
Google Scholar
Gaynes BN, Pence BW, Eron JJ, Miller WC. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV + patient population. Psychosom Med Maggio. 2008;70(4):505–11.
Google Scholar
Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, et al. Prevalence and predictors of Substance Use disorders among HIV Care enrollees in the United States. AIDS Behav Aprile. 2017;21(4):1138–48.
Google Scholar
Sherr L, Nagra N, Kulubya G, Catalan J, Clucas C, Harding R. HIV infection associated post-traumatic stress disorder and post-traumatic growth–a systematic review. Psychol Health Med Ottobre. 2011;16(5):612–29.
Google Scholar
Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry Agosto. 2001;58(8):721–8.
Google Scholar
Vanable PA, Carey MP, Blair DC, Littlewood RA. Impact of HIV-Related Stigma on Health behaviors and Psychological Adjustment among HIV-Positive men and women. AIDS Behav 1 Settembre. 2006;10(5):473–82.
Google Scholar
Lee RS, Kochman A, Sikkema KJ. Internalized Stigma among people living with HIV-AIDS. AIDS Behav 1 Dicembre. 2002;6(4):309–19.
Google Scholar
HIV and Substance Use| NIH [Internet]. [citato 10 febbraio 2024]. Disponibile su: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-substance-use.
Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 30 novembre. 2022;1–9.
Parisi CE, Varma DS, Wang Y, Vaddiparti K, Ibañez GE, Cruz L, et al. Changes in Mental Health among People with HIV during the COVID-19 pandemic: qualitative and quantitative perspectives. AIDS Behav Giugno. 2022;26(6):1980–91.
Google Scholar
SeyedAlinaghi S, Mirzapour P, Pashaei Z, Afzalian A, Tantuoyir MM, Salmani R et al. The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review. AIDS Research and Therapy. 6 gennaio. 2023;20(1):4.
World Health Organization. HIV and COVID-19 [Internet]. 2021 [citato 10 febbraio 2024]. Disponibile su: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/covid-19.
UNAIDS. Prevailing against pandemics by putting people at the centre — World AIDS Day report 2020 [Internet]. [citato 17 marzo 2023]. Disponibile su: https://www.unaids.org/en/resources/documents/2020/prevailing-against-pandemics.
DSM Library [Internet]. [citato 10 febbraio 2024]. Diagnostic and Statistical Manual of Mental Disorders. Disponibile su: https://dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596.
Facts about HIV Stigma| HIV Basics| HIV/AIDS| CDC [Internet]. 2022 [citato 22 marzo 2023]. Disponibile su: https://www.cdc.gov/hiv/basics/hiv-stigma/index.html.
KoboToolbox [Internet]. [citato 20 marzo 2023]. KoboToolbox. Disponibile su: https://www.kobotoolbox.org/.
Maier W, Buller R, Philipp M, Heuser I. The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disorders 1 Gennaio. 1988;14(1):61–8.
Google Scholar
Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1 Gennaio. 1988;8(1):77–100.
Google Scholar
Prins A, Bovin MJ, Smolenski DJ, Marx BP, Kimerling R, Jenkins-Guarnieri MA, et al. The primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J GEN INTERN MED 1 Ottobre. 2016;31(10):1206–11.
Google Scholar
Brown RL, Leonard T, Saunders LA, Papasouliotis O. The prevalence and detection of substance use disorders among inpatients ages 18 to 49: an opportunity for prevention. Prev Med. 1998;27(1):101–10.
Google Scholar
World Health Organization. World mental health report: Transforming mental health for all [Internet]. 2022 [citato 22 marzo 2023]. Disponibile su: https://www.who.int/publications-detail-redirect/9789240049338.
Santomauro DF, Herrera AMM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 6 Novembre. 2021;398(10312):1700–12.
Google Scholar
Gennaro FD, Occa E, Ramirez L, Marotta C, Segala FV, Santana J, et al. Malaria, HIV and Malnutrition among internally displaced people in Mozambique during COVID-19 pandemic: results from a community-based intervention. Ann Glob Health 5 Dicembre. 2022;88(1):106.
Google Scholar
Gennaro FD, Marotta C, Saracino A, Occa E, Putoto G. Mental health needs of adolescents with HIV in Africa. Lancet HIV 1 Giugno. 2022;9(6):e376.
Google Scholar
Lewis KJS, Lewis C, Roberts A, Richards NA, Evison C, Pearce HA, et al. The effect of the COVID-19 pandemic on mental health in individuals with pre-existing mental illness. BJPsych Open 7 Marzo. 2022;8(2):e59.
Google Scholar
van der Velden PG, Marchand M, Das M, Muffels R, Bosmans M. The prevalence, incidence, and risk factors of mental health problems and mental health service use before and 9 months after the COVID-19 outbreak among the general Dutch population. A 3-wave prospective study. PLOS ONE 10 Novembre. 2022;17(11):e0276834.
Google Scholar
Gigantesco A, Minardi V, Contoli B, Masocco M. Depressive symptoms among adults in 2018–2019 and during the 2020 COVID-19 pandemic in Italy. J Affect Disord 15 Luglio. 2022;309:1–8.
Google Scholar
Norwood J, Kheshti A, Shepherd BE, Rebeiro PF, Ahonkhai A, Kelly S, et al. The impact of COVID-19 on the HIV Care Continuum in a large Urban Southern Clinic. AIDS Behav 1 Agosto. 2022;26(8):2825–9.
Google Scholar
Ciccullo A, Borghetti A, Dusina A, Segala F, Visconti E, Tamburrini E et al. The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic. HIV Med [Internet]. gennaio 2021 [citato 7 febbraio 2022];22(1). Disponibile su: https://onlinelibrary.wiley.com/doi/https://doi.org/10.1111/hiv.12936.
Anabwani-Richter F, Swanson T, Dlamini S, Katulege K, Daire C, Singhal G. The Silent Pandemic: the impact of COVID-19 on the Mental Health of adolescents living with HIV. Curr Trop Med Rep. 2022;9(4):207–17.
Google Scholar
Chaponda M, Aldhouse N, Kroes M, Wild L, Robinson C, Smith A. Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UK. Int J STD AIDS 1 Giugno. 2018;29(7):704–13.
Google Scholar
Lang R, Hogan B, Zhu J, McArthur K, Lee J, Zandi P, et al. The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum. AIDS 1 Febbraio. 2023;37(2):259–69.
Levi-Minzi MA, Surratt HL. HIV Stigma among Substance Abusing people living with HIV/AIDS: implications for HIV Treatment. AIDS Patient Care STDS 1 Agosto. 2014;28(8):442–51.
Google Scholar
The ILO Global HIV Discrimination in the World of Work survey [Internet]. 2021 dic [citato 22 marzo 2023]. Disponibile su: http://www.ilo.org/global/publications/books/WCMS_830267/lang–en/index.htm.
Armoon B, Fleury MJ, Bayat AH, Fakhri Y, Higgs P, Moghaddam LF et al. HIV related stigma associated with social support, alcohol use disorders, depression, anxiety, and suicidal ideation among people living with HIV: a systematic review and meta-analysis. International Journal of Mental Health Systems. 4 marzo. 2022;16(1):17.
Scheper H, van Holten N, Hovens J, de Boer M. Severe depression as a neuropsychiatric side effect induced by dolutegravir. HIV Med. 2018;19(4):e58–9.
Google Scholar
Mengato D, Binazzi R, Unterholzner I, Erne EM, Tavella A. Psychiatric disorders after switching to Dolutegravir: a Case Report of a 59-Year-old Virosuppressed HIV-1 positive woman. Case Reports in Infectious Diseases. 15 aprile 2020;2020:e9708913.
Hoffmann C, Welz T, Sabranski M, Kolb M, Wolf E, Stellbrink HJ, et al. Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients. HIV Med. 2017;18(1):56–63.
Google Scholar
Chan P, Goh O, Kroon E, Colby D, Sacdalan C, Pinyakorn S, et al. Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort. AIDS Res Ther 7 Gennaio. 2020;17(1):1.
Google Scholar
Kamkwalala AR, Wang K, O’Halloran J, Williams DW, Dastgheyb R, Fitzgerald KC, et al. Starting or switching to an integrase inhibitor-based regimen affects PTSD symptoms in women with HIV. AIDS Behav Gennaio. 2021;25(1):225–36.
Google Scholar
Jakimiuk A, Piechal A, Wiercińska-Drapało A, Nowaczyk A, Mirowska-Guzel D. Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies. Pharmacol Rep 1 Ottobre. 2023;75(5):1138–51.
Google Scholar
link
